Exon 19 deletion mutations of epidermal growth factor receptor are associated with prolonged survival in non-small cell lung cancer patients treated with gefitinib or erlotinib (Q27851394)
scientific article
Language:
Current Data About Exon 19 deletion mutations of epidermal growth factor receptor are associated with prolonged survival in non-small cell lung cancer patients treated with gefitinib or erlotinib
(P31) (Q13442814)
(P248)
(P698) 16818686
(P813) Sunday, November 13, 2016

(P50) (Q47451221)
(P1545) 13
(P1932) Matthew Meyerson

(Q74766165)
(P1545) 15
(P1932) Pasi A Jänne

(Q5217393)
(P1545) 11
(P1932) Daniel A Haber

(Q90926732)
(P1545) 3
(P1932) Lecia V Sequist

(P304) 3908-14

(P407) (Q1860)

(P433) 13

(P478) 12

(P577) Saturday, July 1, 2006

(P921) (Q3658562)
(P887)

(Q418369)
(P887)

(P1433) (Q332253)

(P1476) "Exon 19 deletion mutations of epidermal growth factor receptor are associated with prolonged survival in non-small cell lung cancer patients treated with gefitinib or erlotinib" (language: en)
(P248)
(P698) 16818686
(P813) Sunday, November 13, 2016

(P2093) David M Jackman
(P1545) 1

Beow Y Yeap
(P1545) 2

Neal Lindeman
(P1545) 4

Alison J Holmes
(P1545) 5

Victoria A Joshi
(P1545) 6

Daphne W Bell
(P1545) 7

Mark S Huberman
(P1545) 8

Balazs Halmos
(P1545) 9

Michael S Rabin
(P1545) 10

Thomas J Lynch
(P1545) 12

Bruce E Johnson
(P1545) 14

other details
description scientific article

External Links
(P356) 10.1158/1078-0432.CCR-06-0462
(P698) 16818686
(P3181) 1345397